Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Laura, Bortesi"'
Autor:
Federico Gobbi, Giulia Martelli, Luciano Attard, Dora Buonfrate, Andrea Angheben, Valentina Marchese, Laura Bortesi, Maria Gobbo, Elisa Vanino, Pierluigi Viale, Zeno Bisoffi
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 9, Iss 7, p e0003860 (2015)
Externí odkaz:
https://doaj.org/article/c5c10d35d2db4c3db4779627bc466870
Publikováno v:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 77
Autor:
Laura Bortesi, Marcella Marconi, Enrico Munari, Giuseppe Zamboni, Matteo Brunelli, Giuseppe Bogina, Alberto Massocco, Maria C Pegoraro, Stefania Gori, Gianluigi Lunardi, Marco Sommaggio
AIMS Primary neuroendocrine (NE) breast carcinoma (BC) is an entity with a wide range of prevalence and poorly defined clinical behaviour. We evaluated the prevalence, clinicopathological features and clinical outcome of NEBC. METHODS AND RESULTS Imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd47f4e742337da7588675bd32876382
http://hdl.handle.net/11379/532974
http://hdl.handle.net/11379/532974
Autor:
Laura Bortesi, Vincenzo Villanacci, Zeno Bisoffi, Giuseppe Zamboni, Luisa Lorenzi, Francesca Liut
Publikováno v:
Journal of Crohn's and Colitis. 6:800-803
Schaumann bodies are inclusion bodies, first described by Schaumann in 1941, typically seen in granulomatous diseases such as tuberculosis, sarcoidosis and chronic beryllium diseases. Williams WJ, in 1964, reported Schaumann bodies to occur in 10% of
Publikováno v:
Surgical Pathology Clinics. 4:487-521
Pancreatic ductal adenocarcinoma (PDAC) and its variants comprise between 80% and 90% of all tumors of the exocrine pancreas. Because of its silent course, late clinical manifestation, and rapid growth, it is considered a silent killer. Only 10% to 1
Autor:
Alvise Cavallini, Stefano Crippa, Giovanni Butturini, Laura Bortesi, Massimo Falconi, Giuliano Barugola
Publikováno v:
Pancreatology. 9:73-80
Pancreatoblastoma is a very uncommon neoplasm in adults and its management represents a great challenge with regards to different treatment options. Given the rarity of the disease, the aim of this study was to review our personal experience with adu
Autor:
Luciano Attard, Valentina Marchese, Maria Gobbo, Dora Buonfrate, Pierluigi Viale, Giulia Martelli, Zeno Bisoffi, Federico Gobbi, Andrea Angheben, Elisa Vanino, Laura Bortesi
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 9, Iss 7, p e0003860 (2015)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
1 Center for Tropical Diseases, Ospedale Sacro-Cuore Don Calabria, Negrar, Verona, Italy, 2 Infectious Diseases Unit, Department of Medical and Surgical Sciences, Ospedale S. Orsola-Malpighi, Alma Mater Studiorum University of Bologna, Bologna, Italy
Autor:
Jennifer Foglietta, Matteo Lambertini, S. Giraudi, Lucia Del Mastro, Guido Ficarra, Laura Medri, Giuseppe Zamboni, Paola Cassandrini, Gianluigi Lunardi, Toni Ibrahim, Laura Bortesi, Corrado Ficorella, Martina Nunzi, Patrizia Serra, Giuseppe Bogina, Marcella Marconi, Laura Cortesi, Elisabetta DeMatteis, Francesca Coati, M. Turazza, Angelo Sidoni, Franca Carli, Maria Rosaria Diadema, Stefania Gori
Publikováno v:
Tumori. 101(4)
Aims and background The aim of this retrospective multicenter study was to evaluate the impact of progesterone receptor (PgR) loss on locoregional recurrence in patients with estrogen receptor (ER)-positive primary breast cancer and ER-positive locor
Autor:
Filippo Alongi, Simona Duranti, Alessandro Inno, Matteo Salgarello, Giuseppe Bogina, Alberto Massocco, Laura Bortesi, Giuseppe Zamboni, M. Turazza, Giovanni Carbognin, Stefania Gori
UNLABELLED : Neuroendocrine carcinoma of the breast is considered a rare entity, and for this reason there are no data from prospective clinical trials on its optimal management. Early stage tumors are usually treated with the same strategy used for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c093c11593ed1544ee7400bab5c6f58e
http://hdl.handle.net/11379/500715
http://hdl.handle.net/11379/500715
Autor:
Massimo Guerriero, Francesca Coati, Matteo Brunelli, Giuseppe Zamboni, Giuseppe Bogina, Matteo Valerio, Maria C Pegoraro, Gianluigi Lunardi, Laura Bortesi, Lisa Marcolini, Marcella Marconi, Alberto Massocco
Triple-negative breast carcinomas represent a tumor group of pivotal clinical importance given the lack of target therapies. The prognostic significance of triple-negative breast carcinomas remains unclear because of their histological and molecular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13c2ce9b9eb419ba13790b149be7e192
http://hdl.handle.net/11562/627200
http://hdl.handle.net/11562/627200